Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Crescent Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025
Period Ending Jun 30, 2025
Cash & Equivalents
152.65M
Short-Term Investments
n/a
Long-Term Investments
n/a
Other Long-Term Assets
1.41M
Receivables
n/a
Inventory
n/a
Other Current Assets
1.58M
Total Current Assets
154.23M
Property-Plant & Equipment
1.8M
Goodwill & Intangibles
n/a
Total Long-Term Assets
3.21M
Total Assets
157.43M
Account Payables
1.65M
Deferred Revenue
n/a
Short-Term Debt
n/a
Other Current Liabilities
3.66M
Total Current Liabilities
16.75M
Long-Term Debt
n/a
Other Long-Term Liabilities
n/a
Total Long-Term Liabilities
1.43M
Total Liabilities
18.18M
Total Debt
1.64M
Common Stock
14K
Retained Earnings
-54.8M
Comprehensive Income
n/a
Shareholders Equity
139.25M
Total Investments
n/a